We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Industry Insights
Targeting “Undruggable” Proteins by Selectively Controlling mRNA Translation
Industry Insight

Targeting “Undruggable” Proteins by Selectively Controlling mRNA Translation

Up to 80% of proteins do not possess binding sites suitable for direct binding of small molecule drugs, making them “undruggable”. To overcome this problem, Anima Biotech has developed a platform to identify drugs with the ability to interfere with the production of these “undruggable” proteins, by selectively inhibiting the translation of mRNA.
Scripps Research Spin-Off Ushers a "New Era" in Vaccinology With Platform Technology
Industry Insight

Scripps Research Spin-Off Ushers a "New Era" in Vaccinology With Platform Technology

Scripps Research spin-off company Ufovax employs the single-component self-assembling protein nanoparticle (1c-SApNP®) platform technology, that was created in the laboratory of Professor Jiang Zhu, to address some of the key challenges in modern vaccine development. We spoke with Dr. Colette Saccomanno to learn more.
Towards a Deeper Understanding of the Proteomic Landscape
Industry Insight

Towards a Deeper Understanding of the Proteomic Landscape

At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.
Progress in Stem Cell Therapy for Transplant, Stroke and ARDS Patients
Industry Insight

Progress in Stem Cell Therapy for Transplant, Stroke and ARDS Patients

Technology Networks spoke with Gil Van Bokkelen, CEO of Athersys, to learn more about MultiStem and the main mechanisms of action the cells have on the body. Gil also discussed some of the additional indications that the cells are being investigated as potential therapies for, including ischemic stroke and acute respiratory distress syndrome (ARDS).
CRISPR: Tips and Tricks for Efficient Delivery Into Primary Cells and Cell Lines
Industry Insight

CRISPR: Tips and Tricks for Efficient Delivery Into Primary Cells and Cell Lines

This article provides tips and tricks for efficient delivery of CRISPR genome editing technology into primary cells and cell lines.
"Technology Dance" Looks Set To Transform the Field of DNA Synthesis
Industry Insight

"Technology Dance" Looks Set To Transform the Field of DNA Synthesis

Codexis and Molecular Assemblies recently announced a partnership through which the companies aim to engineer enzymes that will optimize the process of enzymatic DNA synthesis – an alternative approach to chemical DNA synthesis. Technology Networks spoke with Codexis to find out how this will transform the field of DNA synthesis.
Decoding the Immune System
Industry Insight

Decoding the Immune System

Our immune system is incredibly complex. Developing a complete understanding is an enormous undertaking but one to which scientists have been striving in order to advance disease understanding and improve treatments.
Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial
Industry Insight

Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial

One of the COVID-19 vaccine candidates that received fast track designation by the FDA is mRNA-1273, developed by Moderna, a clinical stage biotechnology company. The company has shared the positive interim results from a Phase I clinical trial of the vaccine in The New England Journal of Medicine .
Real-Time Wastewater Monitoring Enables Rapid COVID-19 Outbreak Detection
Industry Insight

Real-Time Wastewater Monitoring Enables Rapid COVID-19 Outbreak Detection

We spoke to Ari Goldfarb, CEO of Kando, about how their wastewater monitoring technology works and how it is being applied to the current monitoring efforts in the COVID-19 pandemic.
Driving Speed, Sensitivity and Precision in Modern Proteomics
Industry Insight

Driving Speed, Sensitivity and Precision in Modern Proteomics

Technology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.
Advertisement